Back to Speakers

Speaker's Biography

W21149.jpg

Paul Hastings

Chairman and CEO, OncoMed Pharmaceuticals

Paul Hastings is chairman and CEO of OncoMed Pharmaceuticals. Prior to joining OncoMed in 2006, he served in executive-level positions at QLT, Inc., Axys Pharmaceuticals, Chiron BioPharmaceuticals, and LXR Biotechnology. Hastings also held a series of management positions of increasing responsibility at Genzyme Corporation; served as vice president, marketing and sales and general manager, Europe for Synergen, Inc.; and served in marketing and sales management positions for Hoffmann-La Roche. He is currently lead director of Pacira Pharmaceuticals and has or currently serves on the boards of Relypsa, Biotechnology Industry Organization, California Life Sciences Association, Proteolix, and ViaCell. He received a B.S. in pharmacy from the University of Rhode Island.